Healthcare Services company Vijaya Diagnostic Centre announced Q4FY24 & FY24 results: Q4FY24 Financial Highlights: Financial Performance: reported a robust YoY revenue growth of 28.3%, with a total revenue from operations of Rs 1,552.1 million. Profitability: The company observed a Profit after Tax (PAT) increase by 21.7% in Q4FY24, reaching Rs 334.5 million. Operational Metrics: Vijaya Diagnostic Centre revealed operational highlights, showing a Total Tests increase of 24.1% in Q4FY24 compared to Q4FY23. FY24 Financial Highlights: Financial Performance: FY24 showed a substantial revenue increase of 19.3%, accumulating to a total of Rs 5,478.1 million in revenue from operations. Profitability: The annual PAT shot up by 40.4% to Rs 1,188.3 million in FY24. Commenting on the performance Suprita Reddy, MD & CEO said, “I'm happy to share that this quarter too maintained our strong business performance, showcasing exceptional year-over-year revenue growth of 28.3%, of which an impressive 18.5% was achieved organically. This quarter also marked a notable milestone with the wellness contributing 14% of the revenue. After completing six months of productive business operations, our Tier II hub centre in Mahbubnagar has gained a lot of momentum and broken even in just two quarters, showing a high demand for quality diagnostics in the area, and enforcing Vijaya’s reputation as a trusted brand. We have made significant strides toward integrating PH Pune with the parent company. With effect from April 1st, 2024, we have successfully moved all of PH's essential ERP and other IT systems to the parent company's applications. Furthermore, it gives me great pleasure to announce that we have co-branded PH as Vijaya PH. By strategically expanding and directing our capabilities towards future opportunities, we are confident in our ability to consistently deliver lasting value to our stakeholders” Result PDF
Conference Call with Vijaya Diagnostic Centre Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.